PHYSIONEAL 40 GLUCOSE 1.36% CLEAR-FLEX 0.245 G
CALCIUM CHLORIDE : 0.245 G MAGNESIUM CHLORIDE : 0.068 G DEXTROSE : 18.2 G SODIUM CHLORIDE : 19.95 G SODIUM BICARBONATE : 9.29 G SODIUM LACTATE : 6.73 G · DIN 02368730 · VANTIVE ULC
Health Canada status: MARKETED
What is PHYSIONEAL 40 GLUCOSE 1.36% CLEAR-FLEX?
PHYSIONEAL 40 GLUCOSE 1.36% CLEAR-FLEX 0.245 G contains CALCIUM CHLORIDE : 0.245 G MAGNESIUM CHLORIDE : 0.068 G DEXTROSE : 18.2 G SODIUM CHLORIDE : 19.95 G SODIUM BICARBONATE : 9.29 G SODIUM LACTATE : 6.73 G. It is listed in the Health Canada Drug Product Database under DIN 02368730, held by VANTIVE ULC, supplied as SOLUTION for HAEMODIALYSIS (INTRAPERITONEAL) administration. Health Canada currently lists it as marketed, status dated 23-May-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02368730 |
|---|---|
| Brand name | PHYSIONEAL 40 GLUCOSE 1.36% CLEAR-FLEX |
| Generic / active ingredient | CALCIUM CHLORIDE : 0.245 G MAGNESIUM CHLORIDE : 0.068 G DEXTROSE : 18.2 G SODIUM CHLORIDE : 19.95 G SODIUM BICARBONATE : 9.29 G SODIUM LACTATE : 6.73 G |
| Manufacturer | VANTIVE ULC |
| Strength | 0.245 G |
| Dosage form | SOLUTION |
| Route of administration | HAEMODIALYSIS (INTRAPERITONEAL) |
| Schedule | Ethical |
| ATC code | B05ZA HEMODIALYTICS, CONCENTRATES |
| AHFS class | 40:34.00* ; See footnote |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 23-May-2024 |
| Original market date | 2013-02-06 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B05ZA HEMODIALYTICS, CONCENTRATES. 117 of 588 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACID CONCENTRATE 2156 | 10.1 G | SOLUTION | VANTIVE ULC | MARKETED | DIN 02239491 |
| ACID CONCENTRATE 2182 | 262.98 G | SOLUTION | VANTIVE ULC | MARKETED | DIN 02210835 |
| ACID CONCENTRATE A1221 | 3.35 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | DIN 02254344 |
| ACID CONCENTRATE A1222 | 263 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | DIN 02254336 |
| ACID CONCENTRATE A1223 | 9.92 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | DIN 02254328 |
| ACID CONCENTRATE A1224 | 263 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | DIN 02254301 |
| ACID CONCENTRATE A1225 | 263.0 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | DIN 02254298 |
| ACID CONCENTRATE A1226 | 49.5 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | DIN 02254255 |
| ACID CONCENTRATE A1227 | 8.27 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | DIN 02254247 |
| ACID CONCENTRATE A1228 | 49.5 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | DIN 02533774 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.